Skip to content
Pharma Observatory a Scientist.com platform

Condition (MeSH)

Gastroschisis

ClinicalTrials.gov lists 42 trials for Gastroschisis or a narrower condition beneath it. University Hospital, Angers has the most among industry and government lead sponsors, with 2.

MeSH D020139 Musculoskeletal Diseases C05 C16 C23 Listed by Orphanet as a rare disease
Email me this page as a PDF

Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Phase 1 Phase 1 1 Phase 1/2 Phase 1/2 1 Phase 2 Phase 2 1 Phase 2/3 Phase 2/3 1 Phase 3 Phase 3 2 Phase 4 Phase 4 4 Not applicable Not applicable 18 Observational Observational 14 Phase 1 Phase 1 1 Phase 1/2 Phase 1/2 1 Phase 2 Phase 2 1 Phase 2/3 Phase 2/3 1 Phase 3 Phase 3 2 Phase 4 Phase 4 4 Not applicable Not applicable 18 Observational Observational 14

Trials per phase

42 of the 42 trials are tagged with Gastroschisis itself; the rest are tagged with a narrower condition beneath it.

Get the Gastroschisis report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

When did Gastroschisis trials start? (19)

Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.

Trials over time, by phase

  • Phase 1
  • Phase 1/2
  • Phase 2
  • Phase 2/3
  • Phase 3
  • Phase 4
  • Not applicable
  • Observational

Top of scale: 8

2001: 1 trials (Phase 2 1) 2005: 1 trials (Phase 3 1) 2006: 1 trials (Not applicable 1) 2009: 2 trials (Not applicable 2) 2011: 3 trials (Observational 1, Not applicable 2) 2012: 1 trials (Phase 1/2 1) 2013: 2 trials (Observational 1, Not applicable 1) 2014: 3 trials (Observational 1, Phase 4 1, Phase 3 1) 2015: 2 trials (Not applicable 1, Phase 2/3 1) 2016: 2 trials (Observational 1, Not applicable 1) 2017: 2 trials (Observational 1, Phase 4 1) 2018: 8 trials (Observational 2, Not applicable 4, Phase 4 1, Phase 1 1) 2019: 2 trials (Observational 1, Not applicable 1) 2020: 3 trials (Observational 1, Not applicable 2) 2021: 1 trials (Observational 1) 2022: 1 trials (Observational 1) 2023: 3 trials (Not applicable 2, Phase 4 1) 2024: 2 trials (Observational 2) 2025: 2 trials (Observational 1, Not applicable 1)

Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.

Trials started per year
Year Trials started
2025 2
2024 2
2023 3
2022 1
2021 1
2020 3
2019 2
2018 8
2017 2
2016 2

No forecast is made for this condition: it averages 1.6 trial starts a year over the five years to September, under the 5 a year the method needs.

Recruitment duration, a model prediction: 4 trials still running at the 2026-10-09 snapshot, fewer than the 5 needed for a median. Source: ClinicalTrials.gov / AACT (CTTI), public domain.

What phase are Gastroschisis trials in? (8)

Shown in this order: phase order.

Show the trials by phase as a table
Trials by phase
Phase Trials
Phase 1 1
Phase 1/2 1
Phase 2 1
Phase 2/3 1
Phase 3 2
Phase 4 4
Not applicable 18
Observational 14

How many Gastroschisis trials are recruiting? (6)

Shown in this order: the order a trial moves through, from not yet recruiting to unknown.

Trials by recruitment status
Status Trials
Recruiting 6
Active, not recruiting 2
Completed 13
Terminated 9
Withdrawn 2

Status as registered on ClinicalTrials.gov. Each trial is counted once.

Which lead sponsors run the most Gastroschisis trials? (1)

Shown in this order: most trials first. Lead sponsors the registry classes as industry, NIH, US federal, other government or network. A hospital or university the registry files as government can appear here. Sponsors it classes as academic or other are shown on the full page, because that class cannot separate an institution from a named investigator.

Lead sponsors
Sponsor Trials
University Hospital, Angers 2

Which drugs are being tested for Gastroschisis? (2)

Shown in this order: most trials first. One row per drug, matched to a single molecule under all its names, ranked by number of trials.

Drugs tested
Drug Trials
Glucagon like peptide-2 1
Glycerin Suppository 1

Interventions as named in the registry (8)

Shown in this order: most trials first.

Interventions as named in the registry
Drug Trials
Local Anesthetic 1
Peritoneal Dialysis Solution/Dextrose 1.5% 1
No Intervention -- Observational study 1
Indocyanine Green dye 1
Parenteral Nutrition 1

These are the names sponsors entered on ClinicalTrials.gov that we have not matched to a single molecule. Some are drugs under a brand or code name; others are procedures, doses or arm labels.

Which serious adverse events do Gastroschisis trials report? (3)

Shown in this order: most subjects affected first. Subjects affected summed across trials, a cross-trial signal, not a rate.

Serious adverse events in this condition's trials
Adverse event Subjects affected Trials
Elevated GGT 5 1
Elevated INR 4 1
Short Bowel Syndrome 2 1

Which publications cover Gastroschisis? (68)

Shown in this order: major-topic papers first, then newest, then most linked to trials.

Publications
Publication Journal Year Major topic
Prenatal ultrasound markers for prediction of complex gastroschisis-single-center retrospective cohort study. Journal of perinatology : official journal of the California Perinatal Association 2024 Yes
Evaluation of gastroschisis feeding protocol: A retrospective cohort study. Journal of paediatrics and child health 2024 Yes
Gastroschisis: a systematic review of diagnosis, prognosis and treatment. The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians 2022 Yes
Use of breast milk in infants with uncomplicated gastroschisis: A retrospective cohort study. Journal of pediatric surgery 2022 Yes
Regional variation in gastroschisis: a nationwide database review of demographics and outcomes. Pediatric surgery international 2021 Yes

Prevalence (60)

Shown in this order: jurisdiction, then disease name. Orphanet observation for the mapped ORPHA concept; the mapping relation column says whether that concept is exactly this condition or broader or narrower.

Prevalence
Orphanet disease Type Class Geography Jurisdiction Mapping relation
Gastroschisis Prevalence at birth 1-5 / 10 000 United Kingdom GB Exact
Gastroschisis Prevalence at birth 1-5 / 10 000 United Kingdom GB Exact
Gastroschisis Prevalence at birth 1-5 / 10 000 United Kingdom GB Unspecified
Gastroschisis Prevalence at birth 1-5 / 10 000 Croatia Not stated Unspecified
Gastroschisis Prevalence at birth 1-5 / 10 000 Portugal Not stated Unspecified

Rare-disease identity (2)

Shown in this order: exact, broader, narrower, other.

Rare-disease identity
Orphanet disease ORPHA code Relation Source
Gastroschisis 2368 Exact Orphadata Science knowledge files, Product 1
Gastroschisis 2368 Exact Orphanet Rare Disease Ontology (ORDO)

Not on this page

Not measured: delivery record.

Checked, with nothing recorded for this condition: sub-conditions in mesh.

Browse all condition evidence pages